# Aclaris Therapeutics, Inc.: Form 8-K, filed Feb 27, 2024

- Company: [Aclaris Therapeutics, Inc.](/companies/acrs.md) (CIK 1557746)
- Form: 8-K
- Filed: 2024-02-27
- Accepted by EDGAR: Feb 27, 2024, 07:14 ET
- Period: 2024-02-27
- Accession: 0001558370-24-001752
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/acrs-20240227x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/acrs-20240227x8k.htm

Filed Feb 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-001752. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.